|Articles|September 1, 2003

September 2003
Volume 9
Issue 9

Effects of Protocol-Driven Care Versus Usual Outpatient Clinic Care on Survival Rates in Patients With Type 2 Diabetes

Author(s)Wing Yee So, MRCP, Peter C. Y. Tong, PhD, Gary T. C. Ko, FRCPI

Download PDF: Effects of Protocol-Driven Care Versus Usual Outpatient Clinic Care on Survival Rates in Patients With Type 2 Diabetes

Articles in this issue

almost 23 years ago

Article

Validation of Data Collection for the HEDIS Performance Measure on Chlamydia Screening in an MCO

almost 23 years ago

Article

Improvements in Access to Care for HIV and AIDS in a Statewide Medicaid Managed Care System

almost 23 years ago

Article

The Public's Opinions of Physicians: Do Perceived Choice and Exercised Choice Matter?

almost 23 years ago

Article

The Effect of HMO Competition on Gatekeeping, Usual Source of Care, and Evaluations of Physician Thoroughness

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

The Effect of Medicaid Reimbursement for Psychiatrists on the Health Care Burden of Serious Mental Illness

ByOnur Baser, PhD, MS,Heidi C. Waters, PhD,Nehir Yapar, BS,Gabriela Samayoa, MD, MPH,Xue Han, PhD,Deborah Freedman, MBA,Lauren Isenman, MPH,Rashmi Patel, MD, PhD

June 12th 2026

Association of Travel Nursing With Quality Outcomes in Hospitalized Patients

ByJason Bartock, MD,Adam Green, MD,Raquel Nahra, MD,Amy Bordogna, MD,Amir Davoodi, MD,Jean-Sebastien Rachoin, MD

June 11th 2026

Cost of Behavioral Messaging Interventions for Cardiovascular Medication Adherence

ByDana R. Fletcher, PhD,Lisa M. Sandy, MA,Joy Waughtal, MPH,Cole Hoffman, MS,Sylvie Novins-Montague, BA,Patrick Hosokawa, MS,Pamela N. Peterson, MD, MSPH,Larry A. Allen, MD, MPH,Sheana Bull, PhD,P. Michael Ho, MD, PhD

June 10th 2026

Changes in Persistence to Basal Insulin Following the Medicare Out-of-Pocket Cost Cap

ByRazanne Oueini, PharmD,Ben Shirley, BS,Christie Teigland, PhD,Melissa Castora-Binkley, PhD, MA,Scott Bilder, PhD,Kiran Sunkari, MS,Lynn Pezzullo, RPh

June 8th 2026

US map with stethoscope | Image Credit: © Andreas Prott - stock.adobe.com

Associations Between Socioeconomic Status, Healthy Lifestyle, and Multimorbidity in the US

ByShifeng Wu, MM

June 5th 2026

Effects of Protocol-Driven Care Versus Usual Outpatient Clinic Care on Survival Rates in Patients With Type 2 Diabetes

Articles in this issue

Related Content

The Effect of Medicaid Reimbursement for Psychiatrists on the Health Care Burden of Serious Mental Illness

Association of Travel Nursing With Quality Outcomes in Hospitalized Patients

Cost of Behavioral Messaging Interventions for Cardiovascular Medication Adherence

Changes in Persistence to Basal Insulin Following the Medicare Out-of-Pocket Cost Cap

Associations Between Socioeconomic Status, Healthy Lifestyle, and Multimorbidity in the US

Trending on AJMC

Patient Portal Messages Outpace Office Visits

Legend Biotech’s CAR T-cell Therapy Shows Early Promise in SCLC, Other Tumors

Flatiron’s AI-Driven Telescope Makes Data Access More User-Friendly

A Case for SGLT2 Inhibitors in Non-Diabetic CKD: Sandra Chaparro, MD

FDA Issues Complete Response Letter for Cytisinicline NDA, Citing Manufacturing Deficiencies

Access, Affordability, & Accountability: A New Era in Oncology Reimbursement

Effects of Protocol-Driven Care Versus Usual Outpatient Clinic Care on Survival Rates in Patients With Type 2 Diabetes

Articles in this issue

Related Content

The Effect of Medicaid Reimbursement for Psychiatrists on the Health Care Burden of Serious Mental Illness

Association of Travel Nursing With Quality Outcomes in Hospitalized Patients

Cost of Behavioral Messaging Interventions for Cardiovascular Medication Adherence

Changes in Persistence to Basal Insulin Following the Medicare Out-of-Pocket Cost Cap

Associations Between Socioeconomic Status, Healthy Lifestyle, and Multimorbidity in the US

Trending on AJMC

Patient Portal Messages Outpace Office Visits

Legend Biotech’s CAR T-cell Therapy Shows Early Promise in SCLC, Other Tumors

Flatiron’s AI-Driven Telescope Makes Data Access More User-Friendly

A Case for SGLT2 Inhibitors in Non-Diabetic CKD: Sandra Chaparro, MD

FDA Issues Complete Response Letter for Cytisinicline NDA, Citing Manufacturing Deficiencies